palladium has been researched along with carboplatin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rau, T; van Eldik, R | 1 |
Hamácek, J; Havel, J | 1 |
Dvorák, Z; Starha, P; Trávnícek, Z; Vrzal, R | 1 |
1 review(s) available for palladium and carboplatin
Article | Year |
---|---|
Mechanistic insight from kinetic studies on the interaction of model palladium (II) complexes with nucleic acid components.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Drug Design; Humans; Kinetics; Neoplasms; Nucleosides; Nucleotides; Palladium; Platinum; Purines; Pyrimidines | 1996 |
2 other study(ies) available for palladium and carboplatin
Article | Year |
---|---|
Determination of platinum (II,IV) and palladium(II) as thiocyanate complexes by capillary zone electrophoresis analysis of carboplatin and similar drugs.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Electrophoresis, Capillary; Palladium; Platinum; Spectrophotometry; Thiocyanates; Vehicle Emissions | 1999 |
Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
Topics: Adenine; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cisplatin; HeLa Cells; Hepatocytes; Humans; Inhibitory Concentration 50; Molecular Structure; Organometallic Compounds; Organoplatinum Compounds; Oxaliplatin; Palladium; Platinum | 2010 |